Egleston Children's Hospital at Emory University, INC.

Egleston Children's Hospital at Emory University, INC. was paid $222.59M by Medicaid between Jan 2018 and Dec 2024, across 584 billing codes. Its largest line is 99285, emergency room visit (most serious) — 20% of everything it billed.

33Billing provider infoEGLESTON CHILDREN'S HOSPITAL AT EMORY UNIVERSITY, INC.
ATLANTA, GA 30322

33aNPI1558416701assigned 01/25/2007

33bProvider typePediatric Nurse Practitioner

28Total paid$222.59M

24GClaims1,940,630

24DCodes billed584

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Pediatric Nurse Practitioner providers in Georgia

Rank by total paid#1 of 10

Median peer was paid$12K

This provider vs. median18,570×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	424,553	$45.54M
2019	396,224	$45.23M
2020	258,838	$29.52M
2021	242,858	$28.90M
2022	208,632	$22.88M
2023	208,211	$24.36M
2024incomplete	201,314	$26.16M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	20%	68,052	62,632	$45.54M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	13%	171,540	166,661	$28.60M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	12%	74,520	71,913	$26.48M
G0378	Hospital observation service, per hour	2.7%	17,137	8,515	$6.08M
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	2.4%	2,159	1,692	$5.39M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	2.3%	1,625	1,417	$5.20M
70551	Magnetic resonance imaging, brain; without contrast material	1.9%	4,453	4,203	$4.22M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.7%	2,123	1,995	$3.78M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.4%	2,094	1,963	$3.08M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	1.3%	30,168	25,513	$2.89M
95810	Polysomnography; sleep staging with 4 or more additional parameters	1.3%	1,754	1,706	$2.87M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.3%	8,086	5,344	$2.80M

572 more codes

P9016	Red blood cells, leukocytes reduced, each unit	1.2%	2,678	$2.67M
95782		1.1%	1,415	$2.37M
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	1,386	$2.22M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	23,225	$1.96M
93325		<1%	9,808	$1.79M
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	1,703	$1.74M
J9312	Injection, rituximab, 10 mg	<1%	255	$1.63M
92611		<1%	4,130	$1.63M
74230		<1%	4,109	$1.61M
71046	Radiologic examination, chest; 2 views	<1%	23,640	$1.58M
74183		<1%	948	$1.56M
70543		<1%	816	$1.49M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	14,986	$1.42M
70450	Computed tomography, head or brain; without contrast material	<1%	4,163	$1.35M
94776		<1%	3,412	$1.32M
93975		<1%	2,777	$1.27M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	1,795	$1.24M
37241		<1%	367	$1.17M
76825		<1%	1,528	$1.17M
36430		<1%	2,753	$1.16M
93321		<1%	6,096	$1.05M
J3490	Unclassified drugs	<1%	59,471	$971K
J0586	Injection, abobotulinumtoxina, 5 units	<1%	1,071	$922K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	8,309	$894K
72197		<1%	523	$887K
99214	Doctor's office visit, returning patient (more involved)	<1%	7,426	$867K
96450		<1%	1,540	$864K
96361	Intravenous infusion, hydration; each additional hour	<1%	12,609	$839K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	101,039	$833K
80053	Comprehensive metabolic panel	<1%	72,999	$829K
76770		<1%	3,025	$827K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	591	$795K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	10,852	$783K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	5,768	$756K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	5,865	$734K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,957	$723K
74019		<1%	9,123	$720K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	10,032	$661K
71555		<1%	512	$646K
86920		<1%	2,879	$643K
96409		<1%	3,564	$642K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	17,309	$641K
93308		<1%	3,487	$638K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	<1%	234	$628K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	670	$621K
93304		<1%	2,934	$616K
75565		<1%	896	$575K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,010	$572K
96415		<1%	1,819	$550K
64642		<1%	2,485	$544K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	695	$517K
76827		<1%	1,545	$497K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	521	$493K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	1,232	$461K
54161		<1%	403	$450K
86833		<1%	4,714	$444K
75573		<1%	212	$442K
99215	Doctor's office visit, returning patient (complex)	<1%	2,882	$432K
D0230	Intraoral - periapical each additional radiographic image	<1%	829	$430K
74240		<1%	981	$423K
D9420		<1%	184	$419K
87799		<1%	16,000	$407K
86832		<1%	4,708	$400K
87497		<1%	8,681	$388K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	724	$373K
J2704	Injection, propofol, 10 mg	<1%	31,554	$369K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	82	$365K
75561		<1%	267	$356K
94775		<1%	2,818	$347K
96375	Therapeutic injection; each additional sequential IV push	<1%	7,237	$344K
51701		<1%	5,441	$340K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	11,387	$336K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	8,781	$333K
99203	Doctor's office visit, new patient (routine)	<1%	2,116	$315K
93320		<1%	1,679	$313K
76536		<1%	1,410	$303K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	3,761	$302K
74018		<1%	6,051	$299K
88185		<1%	1,239	$296K
J3262	Injection, tocilizumab, 1 mg	<1%	171	$296K
70486		<1%	461	$292K
49465		<1%	1,120	$278K
96367		<1%	2,129	$277K
31622		<1%	577	$269K
95819		<1%	513	$267K
80197		<1%	16,582	$267K
95812		<1%	515	$257K
64643		<1%	2,502	$251K
93886		<1%	401	$245K
D0220	Intraoral - periapical first radiographic image	<1%	835	$244K
86828		<1%	4,899	$238K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,499	$235K
71045	Radiologic examination, chest; single view	<1%	7,456	$227K
J9310	Injection, rituximab, 100 mg	<1%	50	$209K
92018		<1%	400	$206K
94668		<1%	2,043	$204K
76942		<1%	1,135	$204K
87086	Culture, bacterial; quantitative colony count, urine	<1%	22,462	$198K
96411		<1%	980	$196K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	4,303	$195K
31526		<1%	155	$184K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	6,680	$177K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	3,953	$173K
72170		<1%	2,472	$172K
82728		<1%	11,631	$172K
D1351	Sealant - per tooth	<1%	362	$169K
83970		<1%	4,298	$167K
88307		<1%	1,318	$166K
72040		<1%	1,920	$159K
54640		<1%	119	$154K
83880		<1%	4,338	$153K
92585		<1%	234	$152K
93296		<1%	1,271	$152K
93531		<1%	83	$144K
93505		<1%	132	$143K
D7140	Extraction, erupted tooth or exposed root	<1%	284	$142K
76870		<1%	845	$142K
87581		<1%	8,299	$139K
87486		<1%	8,281	$139K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	832	$138K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	2,957	$130K
87040		<1%	12,457	$130K
92250		<1%	565	$130K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	3,206	$127K
70544		<1%	263	$126K
J9070	Cyclophosphamide, 100 mg	<1%	352	$125K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	3,991	$125K
73610		<1%	2,724	$123K
73630		<1%	2,540	$123K
73590		<1%	2,164	$120K
43762		<1%	805	$120K
84443	Thyroid stimulating hormone (TSH)	<1%	6,811	$119K
P9011	Blood, split unit	<1%	384	$119K
83735		<1%	13,042	$117K
36512		<1%	64	$115K
76886		<1%	367	$112K
86850		<1%	7,513	$109K
86360		<1%	2,516	$108K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	2,716	$107K
D0272	Bitewings - two radiographic images	<1%	529	$107K
APT15		<1%	9,611	$106K
88342		<1%	2,296	$106K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	10,455	$105K
73090		<1%	2,602	$103K
86922		<1%	1,214	$102K
D1120	Dental cleaning, child	<1%	997	$101K
83690		<1%	7,453	$98K
87507		<1%	777	$96K
93017		<1%	128	$95K
76881		<1%	660	$94K
12011		<1%	1,434	$94K
82784		<1%	6,094	$93K
86140		<1%	19,323	$92K
97162		<1%	807	$92K
85045		<1%	20,836	$91K
42830		<1%	82	$91K
Q5121	Injection, infliximab-axxq, biosimilar, (avsola), 10 mg	<1%	46	$90K
85246		<1%	3,269	$89K
80069		<1%	10,854	$89K
70360		<1%	1,012	$89K
78816		<1%	26	$87K
73552		<1%	1,065	$85K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	30,890	$85K
94644		<1%	4,114	$85K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	190	$83K
93568		<1%	108	$82K
75557		<1%	93	$80K
73130		<1%	1,642	$78K
88184		<1%	1,292	$77K
92587		<1%	952	$77K
73070		<1%	1,610	$75K
49452		<1%	73	$75K
93458		<1%	27	$74K
94660		<1%	169	$72K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	5,721	$71K
70480		<1%	68	$71K
74181		<1%	115	$70K
73560		<1%	823	$70K
88341		<1%	543	$69K
80048	Basic metabolic panel (calcium, ionized)	<1%	9,919	$69K
72100		<1%	879	$69K
88313		<1%	981	$67K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	534	$67K
12001		<1%	742	$67K
86359		<1%	3,009	$65K
87077		<1%	6,864	$65K
86357		<1%	2,519	$65K
86901		<1%	8,301	$64K
73562		<1%	1,289	$63K
86160		<1%	2,384	$62K
82570		<1%	11,614	$61K
J7030	Infusion, normal saline solution , 1000 cc	<1%	22,175	$61K
92652		<1%	96	$61K
86355		<1%	2,514	$60K
D0240		<1%	126	$59K
76885		<1%	187	$57K
92019		<1%	196	$57K
82977		<1%	9,896	$55K
85730		<1%	8,315	$55K
92567		<1%	1,004	$55K
87186		<1%	5,738	$55K
86902		<1%	2,898	$54K
85027		<1%	7,805	$53K
94642		<1%	758	$52K
81001		<1%	19,932	$51K
71250		<1%	64	$51K
77080		<1%	156	$51K
85576		<1%	661	$51K
83550		<1%	5,310	$50K
84439		<1%	5,102	$49K
94621		<1%	46	$48K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	57	$48K
73110		<1%	1,028	$46K
82803		<1%	7,188	$45K
D2930	Prefabricated stainless steel crown - primary tooth	<1%	93	$45K
J9370	Vincristine sulfate, 1 mg	<1%	3,640	$45K
85610		<1%	9,583	$45K
82330		<1%	8,618	$45K
20680		<1%	26	$44K
88304		<1%	1,244	$44K
77072		<1%	344	$43K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,793	$42K
85240		<1%	1,870	$42K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	12	$42K
83540		<1%	5,721	$41K
70250		<1%	357	$41K
83036	Hemoglobin; glycosylated (A1C)	<1%	4,729	$41K
86003		<1%	356	$41K
80061	Lipid panel	<1%	5,121	$41K
86356		<1%	625	$41K
J2997	Injection, alteplase recombinant, 1 mg	<1%	115	$40K
75820		<1%	231	$40K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	19,185	$39K
APT16		<1%	3,078	$39K
80195		<1%	2,732	$38K
86665		<1%	944	$37K
87070		<1%	4,571	$37K
43760		<1%	271	$36K
72081		<1%	278	$36K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	2,275	$36K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	31,351	$36K
85652		<1%	12,226	$35K
81003		<1%	20,967	$34K
83020		<1%	6,669	$34K
01922		<1%	102	$33K
80158		<1%	1,317	$33K
81025		<1%	7,293	$33K
81268		<1%	364	$33K
84156		<1%	8,781	$33K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	568	$33K
85245		<1%	1,148	$32K
94726		<1%	314	$32K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	634	$32K
93597		<1%	40	$31K
86480		<1%	440	$31K
83520		<1%	785	$31K
94680		<1%	344	$31K
86900		<1%	8,300	$30K
73030		<1%	485	$30K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	7,315	$30K
85660		<1%	3,551	$29K
93280		<1%	90	$29K
24538		<1%	13	$29K
85999		<1%	1,209	$29K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,034	$28K
76937		<1%	579	$28K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	839	$28K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	2,202	$27K
P9045	Infusion, albumin (human), 5%, 250 ml	<1%	107	$27K
73140		<1%	712	$26K
99204	Doctor's office visit, new patient (more involved)	<1%	149	$26K
J7050	Infusion, normal saline solution, 250 cc	<1%	7,357	$26K
D7111		<1%	130	$26K
85384		<1%	2,662	$25K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	21,325	$25K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	26	$25K
49585		<1%	16	$25K
77075		<1%	84	$24K
94667		<1%	1,063	$24K
86256		<1%	1,646	$24K
31624		<1%	26	$24K
82248		<1%	4,555	$24K
44970		<1%	13	$24K
85397		<1%	774	$23K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	2,123	$23K
J0690	Injection, cefazolin sodium, 500 mg	<1%	9,894	$22K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	1,312	$22K
D7240	Removal of impacted tooth - completely bony	<1%	12	$21K
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	8,137	$21K
76010		<1%	348	$21K
82105		<1%	870	$21K
94060		<1%	178	$21K
84100		<1%	9,127	$20K
86664		<1%	1,165	$20K
49446		<1%	14	$19K
88240		<1%	691	$19K
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,911	$19K
86235		<1%	149	$19K
73060		<1%	290	$18K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	3,576	$18K
99460		<1%	183	$18K
72141		<1%	25	$17K
87340		<1%	1,903	$17K
96376		<1%	663	$17K
36590		<1%	17	$16K
83615		<1%	5,071	$16K
90686		<1%	4,146	$16K
84703		<1%	3,348	$16K
72070		<1%	210	$16K
85379		<1%	1,520	$15K
93567		<1%	27	$15K
85520		<1%	994	$15K
94664		<1%	2,206	$14K
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	1,236	$14K
83516		<1%	910	$14K
12002		<1%	110	$14K
95716		<1%	16	$14K
86663		<1%	927	$13K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	26,618	$13K
87081		<1%	3,280	$13K
10060		<1%	102	$13K
74455		<1%	39	$13K
86039		<1%	872	$12K
51600		<1%	43	$12K
APT04		<1%	1,082	$12K
P9037	Platelets, pheresis, leukocytes reduced, irradiated, each unit	<1%	26	$12K
94645		<1%	645	$12K
88108		<1%	417	$12K
82043		<1%	1,685	$12K
86706		<1%	1,397	$11K
J1756	Injection, iron sucrose, 1 mg	<1%	328	$11K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	43	$11K
82550		<1%	3,071	$11K
87205		<1%	4,203	$11K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	3,084	$11K
93971		<1%	57	$11K
82785		<1%	513	$10K
72146		<1%	12	$10K
86645		<1%	388	$10K
86644		<1%	482	$10K
88348		<1%	58	$10K
APT17		<1%	770	$10K
82810		<1%	2,168	$9K
97161		<1%	143	$9K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	3,637	$9K
88344		<1%	118	$9K
J9260	Injection, methotrexate sodium, 50 mg	<1%	1,838	$9K
82150		<1%	1,562	$8K
80143		<1%	1,119	$8K
88188		<1%	148	$8K
70491		<1%	12	$8K
60000		<1%	37	$8K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	780	$8K
80179		<1%	1,075	$8K
80180		<1%	1,573	$8K
86803		<1%	480	$8K
84630		<1%	634	$8K
86147		<1%	113	$8K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	1,530	$7K
83002		<1%	322	$7K
82247		<1%	1,921	$7K
84305		<1%	225	$7K
D1206	Topical application of fluoride varnish	<1%	160	$7K
76506		<1%	27	$7K
82525		<1%	488	$7K
86146		<1%	116	$7K
84999		<1%	14	$7K
83718		<1%	660	$7K
90732		<1%	72	$7K
86592		<1%	1,814	$7K
J1644	Injection, heparin sodium, per 1000 units	<1%	5,165	$7K
25600		<1%	55	$7K
89051		<1%	2,628	$7K
86376		<1%	338	$6K
82533		<1%	174	$6K
84403		<1%	195	$6K
87075		<1%	649	$6K
82085		<1%	532	$6K
25605		<1%	26	$6K
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	41	$6K
85670		<1%	892	$6K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	294	$6K
29105		<1%	132	$6K
85014		<1%	6,733	$6K
86317		<1%	155	$6K
84446		<1%	376	$6K
82077		<1%	879	$6K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	6,023	$6K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	913	$6K
80164		<1%	461	$5K
J0290	Injection, ampicillin sodium, 500 mg	<1%	1,536	$5K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	969	$5K
94729		<1%	58	$5K
S0077	Injection, clindamycin phosphate, 300 mg	<1%	1,606	$5K
83921		<1%	260	$5K
92610		<1%	42	$5K
83001		<1%	221	$5K
J1815	Injection, insulin, per 5 units	<1%	207	$5K
82610		<1%	354	$5K
95816		<1%	14	$5K
69210		<1%	19	$5K
25565		<1%	17	$5K
94375		<1%	126	$5K
82670		<1%	146	$5K
86800		<1%	234	$5K
82820		<1%	778	$5K
82340		<1%	645	$5K
94799		<1%	468	$5K
82542		<1%	487	$4K
10061		<1%	27	$4K
85018		<1%	3,103	$4K
82948		<1%	3,681	$4K
92579		<1%	37	$4K
93225		<1%	14	$4K
84550		<1%	1,137	$4K
84295		<1%	5,674	$4K
88346		<1%	93	$4K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	2,130	$4K
88311		<1%	197	$4K
87529		<1%	89	$4K
80076		<1%	445	$4K
90472	Immunization administration, each additional vaccine (list separately)	<1%	298	$3K
82103		<1%	185	$3K
84484		<1%	369	$3K
73000		<1%	76	$3K
73080		<1%	51	$3K
84132		<1%	5,668	$3K
82947		<1%	6,778	$3K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	73	$3K
83090		<1%	190	$3K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	811	$3K
86364		<1%	102	$3K
S5553	Insulin, long acting; 5 units	<1%	266	$3K
82607		<1%	164	$3K
S5551	Insulin, most rapid onset (lispro or aspart); 5 units	<1%	318	$3K
62270		<1%	15	$3K
J2780	Injection, ranitidine hydrochloride, 25 mg	<1%	127	$3K
82104		<1%	138	$3K
80074		<1%	58	$3K
APT18		<1%	225	$3K
29125		<1%	90	$3K
95700		<1%	32	$3K
83050		<1%	729	$3K
88312		<1%	63	$3K
83498		<1%	72	$3K
87206		<1%	359	$3K
84480		<1%	150	$3K
84590		<1%	210	$3K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	2,879	$3K
J7999	Compounded drug, not otherwise classified	<1%	2,291	$2K
90734		<1%	45	$2K
82310		<1%	1,380	$2K
99238	Hospital discharge day management, 30 minutes or less	<1%	31	$2K
82397		<1%	114	$2K
87102		<1%	254	$2K
69200		<1%	16	$2K
84255		<1%	73	$2K
82390		<1%	128	$2K
APT09		<1%	202	$2K
87116		<1%	54	$2K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	298	$2K
87015		<1%	328	$2K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	98	$2K
86880		<1%	255	$2K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	79	$2K
29505		<1%	66	$2K
84145		<1%	156	$2K
82375		<1%	707	$2K
85347		<1%	1,371	$2K
70355		<1%	15	$2K
31720		<1%	32	$2K
81379		<1%	14	$2K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	609	$2K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	12	$2K
76932		<1%	15	$2K
87522	Neg quan hep c or qual rna	<1%	33	$2K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	534	$1K
72072		<1%	25	$1K
J3360	Injection, diazepam, up to 5 mg	<1%	89	$1K
82565		<1%	332	$1K
90715		<1%	78	$1K
J2060	Injection, lorazepam, 2 mg	<1%	438	$1K
86341		<1%	27	$1K
85613		<1%	112	$1K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	1,107	$1K
84146		<1%	47	$1K
90656		<1%	414	$1K
85732		<1%	76	$1K
83883		<1%	81	$1K
82652		<1%	26	$1K
J0613	Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg	<1%	33	$1K
84402		<1%	31	$1K
85044		<1%	225	$1K
99051		<1%	57	$1K
APT02		<1%	130	$872.89
82024		<1%	18	$872.50
85335		<1%	51	$868.02
82746		<1%	45	$859.49
16020		<1%	16	$832.36
82270		<1%	295	$807.63
73660		<1%	15	$806.87
84075		<1%	213	$797.83
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	186	$767.27
90620		<1%	17	$759.58
24640		<1%	14	$741.96
86431		<1%	102	$719.73
84520		<1%	215	$712.60
J9255	Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg	<1%	154	$705.27
86696		<1%	17	$695.47
87045		<1%	39	$684.88
87517		<1%	13	$658.80
J1171	Injection, hydromorphone, 0.1 mg	<1%	190	$658.73
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	58	$651.12
83605		<1%	52	$642.67
S0030	Injection, metronidazole, 500 mg	<1%	52	$629.28
84244		<1%	21	$610.67
86695		<1%	17	$606.39
86769		<1%	14	$590.44
J9040	Injection, bleomycin sulfate, 15 units	<1%	28	$563.90
93041		<1%	30	$536.10
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	213	$528.48
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	109	$494.66
82657		<1%	48	$481.79
80183		<1%	29	$478.07
83789		<1%	59	$458.72
86812		<1%	14	$450.37
J1956	Injection, levofloxacin, 250 mg	<1%	63	$447.58
80299		<1%	49	$444.22
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	12	$434.48
0071A		<1%	55	$425.03
84478		<1%	175	$419.81
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	90	$389.38
85250		<1%	16	$388.16
86308		<1%	115	$376.74
0124A		<1%	20	$320.88
APT11		<1%	31	$315.12
87147		<1%	178	$313.10
86200		<1%	16	$264.31
S0080	Injection, pentamidine isethionate, 300 mg	<1%	43	$243.56
81015		<1%	71	$242.25
84466		<1%	15	$229.74
J1953	Injection, levetiracetam, 10 mg	<1%	53	$228.08
80339		<1%	14	$211.35
82140		<1%	20	$208.60
80187		<1%	17	$201.58
90685		<1%	99	$183.51
J0694	Injection, cefoxitin sodium, 1 gm	<1%	28	$182.32
J3489	Injection, zoledronic acid, 1 mg	<1%	14	$173.76
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	18	$171.52
S5571	Insulin delivery device, disposable pen (including insulin); 3 ml size	<1%	12	$171.40
87046		<1%	39	$170.78
S0164	Injection, pantoprazole sodium, 40 mg	<1%	21	$162.69
82139		<1%	30	$153.30
84436		<1%	30	$148.14
0054A		<1%	12	$108.70
86704		<1%	15	$99.37
S0028	Injection, famotidine, 20 mg	<1%	15	$96.81
J2550	Injection, promethazine hcl, up to 50 mg	<1%	57	$90.07
84030		<1%	14	$90.04
J3480	Injection, potassium chloride, per 2 meq	<1%	65	$89.50
0003A		<1%	16	$89.50
96523		<1%	15	$78.47
J7070	Infusion, d5w, 1000 cc	<1%	23	$72.75
J1940	Injection, furosemide, up to 20 mg	<1%	38	$61.54
84300		<1%	14	$60.69
82945		<1%	12	$53.26
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	13	$13.56
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	16	$4.80
94760		<1%	1,363	$1.48
D1208	Topical application of fluoride, excluding varnish	0%	116	$0.00
81382		0%	14	$0.00
99053		0%	790	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCODY, LOUETTA (MANAGER, PROVIDER ENROLLMENT)

Same official

Other billing entities under CODY, LOUETTA

Full network →

Provider	Location	Paid
Egleston Pediatric Group	Atlanta, GA	$398K
Scottish Rite Childrens Medical CTR	Atlanta, GA	$1K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.